BioVirtus is a full-service early phase clinical sites' network located in Poland (CEE).
BioVirtus provides international pharmaceutical and biotech customers with comprehensive, cost effective, and FDA/EMA compliant early clinical studies.
Services include: study design and medical writing, recruitment of subjects and patients, clinical conduct in dedicated site located near Warsaw (45 beds), electronic data capture, data processing and reporting.
BioVirtus expertise include:
> First-in-Man
> Phase I/II healthy & patients, various indications
> Special populations
> Proof-of-Concept
> Bioequivalence
> Bioavailability
> Food effect
> PK/PD studies
> Biosimilars
> Therapeutic equivalence
> Nicotine risk evaluation & smoking-cessation studies.
www.biovirtus.eu